Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis
Status:
Terminated
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether aspirin is effective in
alleviating symptoms of the clinical high risk (CHR) syndrome for psychosis. The
investigators further aim to determine whether it may delay or prevent the onset of psychosis
in those currently experiencing CHR symptoms. As secondary measures the investigators aim to
collect laboratory studies of inflammation markers and genetic samples to determine whether
certain genetic profiles correlate with risk for psychosis, or response to aspirin treatment.